Navigating the Biotech Winter: Strategies for Survival and Growth Amid Ongoing Industry Downturn

biotech downturn, layoff trends, funding challenges, strategic adaptation, innovation, mergers & acquisitions, workforce planning, precision medicine, artificial intelligence, regulatory landscape, survival strategies, growth opportunities

Illumina and Tempus look beyond cancer in new AI-driven genomics deal

Illumina, Genomics, Partnership, High-Throughput Nucleotide Sequencing, Malignant Neoplasms, Artificial Intelligence, Cardiology discipline, Neurology speciality, Immunology, Genetic Profile, Artificial Intelligence, Market

Biotech and Pharma Job Cuts: Opthea and Pfizer Restructure Amid Industry Challenges

Opthea layoffs 2025 , Pfizer staff reduction , Biotech job cuts , Pharma restructuring , Clinical trial failures , Wet AMD treatment , Cost savings programs , Pfizer San Diego layoffs , Biotech industry challenges

Appeals Court Blocks Reinstatement of Fired Federal Probationary Workers, Affecting 20 Agencies

Federal probationary workers, Appeals court decision, Trump administration, Worker reinstatement halt, Federal reduction-in-force statute, Supreme Court stay, Probationary employee firings

The 5 Largest Biopharma Layoffs of Q1 2025: An Overview of Industry Restructuring

Biopharma layoffs 2025, Novartis layoffs, Galapagos layoffs, Bristol Myers Squibb layoffs, Merck cuts, Gilead workforce reduction, Q1 2025 job cuts, biotech restructuring, pharmaceutical industry job losses, industry trends.

Cellares’ cell therapy factory-in-a-box scores coveted advanced manufacturing technology tag from FDA

Cell Therapy, Advanced Manufacturing Technology, United States Food and Drug Administration, Technology, Identifier, Cell Shuttle, production, Cellares, Biologics License Application, Investigational New Drugs